| Literature DB >> 27517082 |
Emeka B Kesieme1, Peter O Okokhere2, Christopher Ojemiega Iruolagbe2, Angela Odike3, Clifford Owobu4, Theophilus Akhigbe5.
Abstract
Background. The diagnosis and treatment of massive pericardial effusion and cardiac tamponade have evolved over the years with a tendency towards a more comprehensive diagnostic workup and less traumatic intervention. Method. We reviewed and analysed the data of 32 consecutive patients who underwent surgery on account of massive pericardial effusion and cardiac tamponade in a semiurban university hospital in Nigeria from February 2010 to February 2016. Results. The majority of patients (34.4%) were between 31 and 40 years. Fourteen patients (43.8%) presented with clinical and echocardiographic feature of cardiac tamponade. The majority of patients (59.4%) presented with haemorrhagic pericardial effusion and the average volume of fluid drained intraoperatively was 846 mL ± 67 mL. Pericardium was thickened in 50% of cases. Subxiphoid pericardiostomy was performed under local anaesthesia in 28 cases. No postoperative recurrence was observed; however 5 patients developed features of constrictive pericarditis. The relationship between pericardial thickness and development of pericardial constriction was statistically significant (p = 0.004). Conclusion. Subxiphoid pericardiostomy is a very effective way of treating massive pericardial effusion. Removing tube after adequate drainage (50 mL/day) and treatment of primary pathology are key to preventing recurrence. There is also a need to follow up patients to detect pericardial constriction especially those with thickened pericardium.Entities:
Year: 2016 PMID: 27517082 PMCID: PMC4969508 DOI: 10.1155/2016/8917954
Source DB: PubMed Journal: Adv Med ISSN: 2314-758X
Demographic characteristics of respondents.
| Demographic variables | Number | % |
|---|---|---|
|
| ||
| 0–10 | 3 | 9.4 |
| 11–20 | 2 | 6.2 |
| 21–30 | 5 | 15.6 |
| 31–40 | 11 | 34.4 |
| 41–50 | 6 | 18.8 |
| 51–60 | 3 | 9.4 |
| >60 | 2 | 6.2 |
|
| ||
|
| ||
| Male | 18 | 56.2 |
| Female | 14 | 43.8 |
|
| ||
|
| ||
| Bacterial infection | 3 | 9.4 |
| Idiopathic | 6 | 18.7 |
| Malignant | 4 | 12.5 |
| Tuberculosis | 14 | 43.8 |
| Steroid-resistant nephritic syndrome | 1 | 3.1 |
| Suspected haemorrhagic fever | 1 | 3.1 |
| Uraemia | 3 | 9.4 |
|
| ||
|
| ||
| <500 | 5 | 15.6 |
| 500–1000 | 17 | 53.1 |
| >1000 | 10 | 31.3 |
|
| ||
|
| ||
| Serous | 10 | 31.3 |
| Haemorrhagic | 19 | 59.4 |
| Purulent | 3 | 9.3 |
Effect of age, pericardial thickness, and nature of effusion on development of pericardial constriction.
| Variables | Development of constrictive pericarditis (CP) |
| ||
|---|---|---|---|---|
| Developed CP | Has not developed CP | |||
|
| 0.409 | |||
| 0–10 | — | 3 | ||
| 11–20 | — | 2 | ||
| 21–30 | 1 | 3 | ||
| 31–40 | 1 | 9 | ||
| 41–50 | 2 | 2 | ||
| 51–60 | 1 | 1 | ||
| >60 | — | 2 | ||
|
| ||||
|
|
| 0.004 | ||
| Present | 12 | 5 | 7 | |
| Absent | 15 | 0 | 15 | |
|
| ||||
|
|
| 0.296 | ||
| Haemorrhagic | 16 | 4 | 12 | |
| Nonhaemorrhagic | 11 | 1 | 10 | |